2021
DOI: 10.1001/jamahealthforum.2021.2861
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the Association Between Medicare Eligibility and Excess Deaths During the COVID-19 Pandemic in the US

Abstract: similar to those of other reliable sources. This cross-sectional regression discontinuity analysis found that entry into Medicare was not associated with the likelihood of death during the COVID-19 pandemic.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 6 publications
0
4
0
Order By: Relevance
“…Because the Datavant mortality data do not contain state identifiers, we are unable to assess data completeness in our individual study states of Florida and Ohio. During the COVID-19 pandemic, Datavant mortality data have been used in other peer-reviewed 15 and publicly available 16 research on excess mortality. The Yale University Institutional Review Board exempted the study from review because the data were deidentified, and reporting adheres to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.…”
Section: Data Sourcementioning
confidence: 99%
“…Because the Datavant mortality data do not contain state identifiers, we are unable to assess data completeness in our individual study states of Florida and Ohio. During the COVID-19 pandemic, Datavant mortality data have been used in other peer-reviewed 15 and publicly available 16 research on excess mortality. The Yale University Institutional Review Board exempted the study from review because the data were deidentified, and reporting adheres to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.…”
Section: Data Sourcementioning
confidence: 99%
“…We estimated the: 1) change (average marginal effect) in incidence rate at the cutoff; 2) monthly change in incidence rates before (January 2018-May 2020) and after (June 2020-December 2021) the cutoff; and 3) excess cases of GDM after the cutoff using previously published methodology. 4 To rule out seasonal or alternate temporal effects on GDM incidence, falsification testing was performed with May 2019 as an alternate cutoff point. This timepoint, 1 year prior to the primary cutoff point, was selected as it would not be expected to be associated with changes in GDM incidence.…”
Section: Methodsmentioning
confidence: 99%
“…In-hospital and out-of-hospital deaths were identified using 3 sources of data: (1) EHR; (2) state Vital Statistics, which collects death certificates with recorded causes of death filed with the state; and (3) a commercial national data source provided by Datavant, which includes deaths from the Social Security Administration’s Death Master File augmented with deaths sourced from funeral homes and newspaper feeds, to construct an individual-level database of more than 80% of the US deaths annually. 21 , 22 Deaths between 2015 and 2020 were analyzed because they were available in all 3 mortality data sources. We used the EHR-deaths as the reference standard to compare the sensitivity and recall measures between the Vital Statistics and the commercial national mortality data source.…”
Section: Methodsmentioning
confidence: 99%